News & Updates

Show Multimedia Only
Ultraprocessed food intake ups mortality risk in T2D patients Ultraprocessed food intake ups mortality risk in T2D patients

Ultraprocessed food intake ups mortality risk in T2D patients

01 Oct 2023

Individuals with type 2 diabetes (T2D) who regularly consume ultraprocessed foods (UPF), regardless of diet quality, appear to have reduced survival and increased cardiovascular disease (CVD) mortality rate, suggests a recent study.

01 Oct 2023
GLP-1RAs reduce weight in overweight/obese individuals without diabetes

GLP-1RAs reduce weight in overweight/obese individuals without diabetes

30 Sep 2023 byStephen Padilla

Treatment with glucagon-like peptide-1 receptor agonists (GLP-1RAs) results in significant weight loss in patients with obesity or overweight without diabetes, a study has shown. In addition, the best GLP-1RA agent appears to be semaglutide, showing superior efficacy and low-to-moderate risk of side effects.

30 Sep 2023